Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: I've noticed that some posters are asking
While I don't disagree with you, I do find it hard to believe TPL could afford such an acquisition. After all, they do have considerably higher cost than us. I find it hard to believe, financially speaking, they could have afforded us at that time. The S/P was well over a dollar when both sides started realizing substantial gains from licensing.
Share
New Message
Please login to post a reply